You have accessJournal of UrologyStone Disease: Surgical Therapy IV1 Apr 2018MP68-15 THE EVOLUTION OF PERCUTANEOUS NEPHROLITHOTOMY: ANALYSIS OF A SINGLE INSTITUTION EXPERIENCE OVER 25 YEARS Jennifer Bjazevic, Linda Nott, John Denstedt, and Hassan Razvi Jennifer BjazevicJennifer Bjazevic More articles by this author , Linda NottLinda Nott More articles by this author , John DenstedtJohn Denstedt More articles by this author , and Hassan RazviHassan Razvi More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2219AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The incidence of nephrolithiasis and the use of percutaneous nephrolithotomy (PCNL) has risen significantly over the years. PCNL aims to achieve a high stone-free rate with a low risk of complications. The objective of our study was to determine the impact of changes in patient demographics and surgical techniques over a 25-year time period, on PCNL outcomes. METHODS A retrospective analysis on a prospectively maintained database, including 2554 consecutive PCNL treatments in 2486 patients from July 1990 to July 2015 was undertaken. Collected data included patient demographics, comorbidities, stone and procedure characteristics, adverse events, and stone-free status at three-month follow-up. Adverse events were categorized according to the Clavien-Dindo classification. Patients were divided into equal terciles, each representing 852 consecutive procedures, ordered chronologically. Chi squared test was used to evaluate changes in patient characteristics and surgical techniques over time. A multivariate logistic regression was used to identify the effect of time on operative duration, adverse events, stone-free rate and hospital length of stay. RESULTS Our cohort had a mean age of 54 ± 15 years, was 66.6% male, had a mean body mass index (BMI) of 31 ± 8, and a mean stone surface area of 895 ± 602 mm2. Medical comorbidities were present in 46.9% of patients, most commonly hypertension (22%), diabetes (14%), and cardiac disease (13%). Overall complication rate was 15.6%, including a 2.5% rate of major complications (Clavien grade 3-5). Three-month follow-up of 1873 available patients showed residual stones in 13.3%. Over time there was a statistically significant increase in patient age, BMI, comorbidities, and ASA score. Over time, both OR duration (mean Δ 16 mins, p<0.001) and hospital length of stay (mean Δ 3 days, p<0.001) decreased significantly. Intra-operatively, there was an increase in the use of the balloon dilator and ultrasonic lithotripter (p<0.001). Stone-free rate decreased significantly over time (OR 1.09, p<0.001), but was correlated with an increased use of CT scans for follow-up imaging. There was an increased complication rate with time (OR 1.15, p=0.010); however, this was correlated with the increased rate of medical comorbidities. The overall transfusion rate was 1.0% and did not change over time (p=0.131). CONCLUSIONS Despite an increasingly complex patient population, PCNL remains a safe and effective procedure for the management of large and complex urolithiasis; resulting in a high stone-free rate and low risk of complications. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e922 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Jennifer Bjazevic More articles by this author Linda Nott More articles by this author John Denstedt More articles by this author Hassan Razvi More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...